Lawmakers attach user fees to CR, plan to revisit riders after mid-terms
Regulatory NewsFerdous Al-Faruque
APIsBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy